U.S. Personal Products Stock News

Analyst coverage sparks fresh attention on NextDecade Capital One Financial has initiated coverage on NextDecade (NEXT) with a buy rating, putting fresh attention on the liquefied natural gas developer and its Rio Grande LNG and carbon capture projects in Texas. See our latest analysis for NextDecade. NextDecade's share price has climbed 6.3% over the past week and 10.0% over the past month to US$5.38, although the 1 year total shareholder return shows a 32.1% decline and the 5 year total...

In the past week, Edwards Lifesciences reported Q4 2025 sales of US$1,569.6 million and full-year 2025 sales of US$6.07 billion, alongside issuing 2026 guidance calling for first-quarter sales of US$1.55 billion to US$1.63 billion and full-year EPS of US$2.90 to US$3.05. While revenue continued to grow, the sharp drop in quarterly and full-year net income and EPS highlights how margin pressure and one-off factors are shaping Edwards’ profit profile as it invests behind its Structural Heart...

In early February 2026, Iovance Biotherapeutics reported real-world data for its commercial Amtagvi (lifileucel) therapy in advanced melanoma, showing what it called a best-in-class profile with unprecedented response rates, while reiterating extensive regulatory, manufacturing, and commercialization risks in its latest disclosures. The company’s detailed risk discussion highlights how fragile this apparent clinical success could be, with uncertainties around ex-U.S. approvals, manufacturing...

Recent coverage around potential US cannabis regulatory shifts, including possible rescheduling to Schedule III and the SAFER Act, has brought Innovative Industrial Properties (IIPR) back into focus for income oriented real estate investors. See our latest analysis for Innovative Industrial Properties. IIPR’s latest share price of $47.99 sits against a backdrop of a 30 day share price return of 5.16% and a year to date share price return of 2.99%. The 1 year total shareholder return of 25.89%...

With no fresh headline driving Hershey (HSY) today, the stock’s recent performance still stands out, with gains over the month, past 3 months, year to date, and the past year drawing investor attention. See our latest analysis for Hershey. Hershey’s recent 30 day share price return of 21.12% and 90 day share price return of 28.46%, against a 1 year total shareholder return of 49.44%, point to momentum building again after a softer multi year profile. If this move has you thinking about where...

In early February 2026, JPMorgan reiterated its positive stance on DLocal, citing record Total Payment Volume and gross profit alongside expanding cross-border payments infrastructure and new offerings like its Buy Now, Pay Later Fuse across multiple emerging markets. The analyst commentary underscored that DLocal’s growing network of local payment methods and product breadth is becoming a key differentiator for merchants seeking access to diverse, cash-light economies. Next, we’ll examine...

Alvotech (ALVO) shares have been in focus after the company reported positive top line pharmacokinetic data for its AVT80 biosimilar candidate to Entyvio, along with new supply and commercialization agreements with Sandoz in Canada, Australia and New Zealand. See our latest analysis for Alvotech. These fresh clinical results and the Sandoz agreements come after a mixed share price pattern, with a 12.07% 1 month share price return and a 4.00% year to date share price return contrasting with a...

Recent share performance and business profile Science Applications International (SAIC) has been in focus for investors after a month return of about a 14% decline, contrasting with an 8.3% gain over the past 3 months and a 5 year total return of 11.8%. The Reston based contractor generates about US$7.35b in annual revenue and US$371m in net income, providing technical, engineering and enterprise IT services across U.S. defense, intelligence and civilian agencies. See our latest analysis for...

Bausch Health Companies has recently attracted renewed investor attention as it works to cut its sizeable debt, address legacy legal issues, and reshape its portfolio across eye health and specialty pharmaceuticals. An interesting angle is how growing social media visibility of Bausch’s key brands is drawing in more retail investors and amplifying interest in its ongoing turnaround efforts. We’ll now examine how this increased focus on Bausch’s debt reduction progress and turnaround...

Applied Digital recently reported a year-over-year revenue increase of 250% and locked in multiple 15-year AI data center leases, including an US$11.00 billion agreement with CoreWeave at its Polaris Forge 1 campus and a long-term contract with a U.S.-based hyperscaler for 200 megawatts at Polaris Forge 2. These contracts, together with more than US$16.00 billion in total long-term lease commitments and new project financing, mark a decisive shift toward recurring AI infrastructure revenue...

Starbucks (NasdaqGS:SBUX) is contending with rising competitive pressure from rivals such as Luckin Coffee in China, Paris Baguette in the US, and McDonald's, which is seeing stronger traction with younger US consumers. The company is seeing lower engagement among users aged 17 to 25 on its app, raising questions about its appeal to younger customers. Dividend growth at Starbucks has slowed sharply, and the current payout is higher than net income, which is prompting fresh scrutiny of how...

Williams-Sonoma: recent performance snapshot Williams-Sonoma (WSM) has drawn fresh attention after a strong multi year total return profile, with the stock also showing gains over the past year, month, and past 3 months. See our latest analysis for Williams-Sonoma. At a share price of $216.78, Williams-Sonoma has seen firmer momentum recently, with a 30 day share price return of 8.9% and a 90 day gain of 13.0%. Its three year total shareholder return of about 2.5x highlights how strong the...

Why West Pharmaceutical Services Is Back in Focus Ahead of Earnings West Pharmaceutical Services (WST) is drawing fresh attention as investors look ahead to its earnings report this Thursday, after the company previously beat earnings and revenue expectations and raised full-year 2025 guidance. See our latest analysis for West Pharmaceutical Services. At a share price of US$243.56, West Pharmaceutical Services has seen a 5.46% 7 day share price return, a 30 day share price return of 11.60%...

Lyft stock snapshot after recent performance shifts Lyft (LYFT) shares have seen mixed recent returns, with a 1.4% move over the past day, a small gain over the past week, and declines over the past month and past 3 months. See our latest analysis for Lyft. At a share price of $16.85, Lyft’s recent 1 day and 7 day share price gains sit against weaker 30 day, 90 day and year to date share price returns, while its 1 year and 3 year total shareholder returns remain positive. This suggests...

In January 2026, Ryman Hospitality Properties, Inc. refinanced and expanded its revolving credit facility from US$700,000,000 to US$850,000,000, extending the initial maturity to January 2030 while keeping pricing and most terms largely unchanged and updating several key financial covenants. This refinancing gives Ryman greater committed liquidity and a longer funding runway, potentially enhancing its flexibility to manage leverage, secured debt levels, and future capital needs under clearly...

CarGurus recently expanded its “Big Deal” brand campaign, rolling out AI-powered tools such as Dealership Mode and CarGurus Discover, while reporting higher average revenue per user, strong EBITDA margins, and growing free cash flow from its online automotive marketplace. An interesting angle is that these AI features are designed to personalize both on-lot and online car shopping, potentially making CarGurus’ platform more central to how dealers manage inventory and engage buyers. Next,...

Jones Lang LaSalle has appointed Mouhammad Takieddin as its new Regional Head and CEO for the Middle East and Africa, based in Riyadh, to drive growth in areas such as data centers, facilities management, and AI-enabled real estate services. By bringing in a leader with deep digital transformation and global corporate real estate experience from Procter & Gamble, JLL is explicitly tying its Middle East and Africa ambitions to technology-enabled, higher-value service offerings. Next, we’ll...

In early February 2026, Carvana expanded its same-day vehicle delivery and pickup service to the greater Eugene area, extending its online platform that lets customers buy, finance, trade in, and sell used cars entirely digitally across more than 20 states. This move highlights how Carvana is leaning on its logistics and reconditioning infrastructure to shorten delivery times and potentially deepen customer engagement in regional markets. We’ll now examine how Carvana’s response to...

Owens Corning (OC) has drawn fresh attention after recent trading, with the stock last closing at $137.97. Investors are weighing this price against the company’s recent returns, as well as its mixed annual revenue and net income trends. See our latest analysis for Owens Corning. The recent 1-day share price return of 1.64% and 7-day share price return of 10.41% sit alongside a 30-day share price return of 12.71% and 90-day share price return of 33.85%. The 1-year total shareholder return of...

Wingstop, ticker NasdaqGS:WING, is expanding in the UK with new locations in Manchester Arndale and Derby Derbion. The company now has more than 85 UK sites and aims to more than double this footprint over the next five years. This push highlights the importance of international markets in Wingstop's growth plans. Wingstop shares recently closed at $259.64, with a return of 53.9% over the past three years and 65.5% over the past five years. The stock has seen a 13.0% decline over the past...

If you are wondering whether Ulta Beauty's share price still reflects good value after a strong run, this article will walk through what the current market price may be implying about the business. Ulta Beauty's stock recently closed at US$679.28, with returns of 0.9% over 7 days, 2.0% over 30 days, 9.6% year to date, 81.4% over 1 year, 29.5% over 3 years and 107.2% over 5 years. Recent news coverage around Ulta Beauty has focused on the company's position in the US beauty retail space and...

Astera Labs (NasdaqGS:ALAB) announced the opening of a new advanced R&D center in Israel focused on AI connectivity and memory solutions. The company disclosed a warrant-linked purchase agreement with Amazon that ties future equity to commercial activity. Astera Labs also appointed a new chief financial officer with extensive industry experience, signaling an organizational shift to support its next phase of growth. Astera Labs, a data and connectivity chip company listed on the NasdaqGS...

If you are wondering whether General Motors at around US$80.27 is offering real value or is mainly being driven by sentiment, this article will help you unpack what the current share price might be indicating. The stock has seen mixed short-term moves, with a 6.3% decline over the last 7 days and a 3.1% decline over 30 days, while still showing a 73.7% return over 1 year and a 95.2% return over 3 years. Recent coverage of General Motors has focused on its position in US autos and ongoing...

Setting the scene with Danaos's latest numbers Danaos (DAC) has just wrapped up FY 2025 with fourth quarter revenue of US$266.3 million and basic EPS of US$6.43, capping a year in which trailing twelve month revenue sat at about US$1.0 billion and EPS at US$26.83. The company has seen revenue move from US$258.2 million and EPS of US$4.72 in Q4 2024 to the latest Q4 2025 figures. Over the same period, trailing twelve month revenue slipped from US$1.01 billion and EPS from US$26.15 a year...